Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of the Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate Plus Amodiaquine Coadministered for the Treatment of Uncomplicated Falciparum Malaria in Zanzibar

NCT03764527 is registered in ClinicalTrials.gov with Professor Anders Björkman as lead sponsor.

NCT NCT03764527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of the Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate Plus Amodiaquine Coadministered for the Treatment of Uncomplicated Falciparum Malaria in Zanzibar
Lead sponsor
Professor Anders Björkman
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2002
Completion date
February 17, 2003
Enrollment
408 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum malaria